Rajesh Jain, Joint MD, Panacea Biotec, said the cut in excise and custom duty will make drug prices more affordable. "The duty cuts will be passed on to consumers, so consumers will be benefited rather than the pharma industry."
There is no mechanism in the Budget to mitigate concerns for an appreciating rupee, he told CNBC-TV18. A 125% weighted deduction on outsourced R&D will be beneficial in the long run, he added.
Link to the article: http://www.moneycontrol.com/india/news/budget-interviews/duty-cut-will-make-drug-prices-affordable:-panacea-biotec/328878
No comments:
Post a Comment